Biolase (BIOL) Tops Q4 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises in broad rebound; yields push markets towards weekly declines
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
- SpaceX shares fall as second lockup period ends
BIOLASE Reports 2015 Fourth Quarter and Year-End Results
March 9, 2016 4:05 PM ESTIRVINE, Calif.--(BUSINESS WIRE)-- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today reported its financial results for the fourth quarter and year ended December 31, 2015.
Selected highlights of the 2015 fourth quarter:
Worldwide revenue of $14.5 million up $1.3 million or 10% year-over-year. Worldwide WaterLase® revenue up 29% year-over-year with a 41% increase in the U.S. and a 12% increase internationally. Quarterly unit sales of our flagship WaterLase® iPlus were the highest in 3 years world-wide and... More